NSAIDs over cyclooxygenase 2-specific inhibitors in the first 2 trimesters, due to lack of data on cyclooxygenase 2-specific inhibitors. Nonfluorinated glucocorticoids should be used when needed, but substitution of steroid-sparing pregnancy-compatible immunosuppressive therapy is desirable when high-dose or prolonged use is required. We conditionally recommend continuing low-dose glucocorticoid treatment (â‰¤10 mg daily of prednisone or nonfluorinated equivalent) during pregnancy if clinically